UCB SA (UNC0.F)
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
109.00-0.06%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+17.2%
The outlook
UCB SA currently reads as bearish based on below its 50- & 200-day averages, 36% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range36% of the way from its 52-week low to high
Market cap
$41.50B
52-wk high
142.00
52-wk low
90.50
50-day avg
124.66
200-day avg
123.73
Trailing P/E
27.1